News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
189,686 Results
Type
Article (8449)
Company Profile (10)
Press Release (181226)
Multimedia
Podcasts (10)
Webinars (3)
Section
Business (57982)
Career Advice (527)
Deals (10370)
Drug Delivery (25)
Drug Development (24559)
Employer Resources (31)
FDA (4272)
Job Trends (4424)
News (95050)
Policy (7387)
Tag
Academia (479)
Accelerated approval (11)
Adcomms (5)
Allergies (65)
Alliances (7278)
ALS (85)
Alzheimer's disease (557)
Antibody-drug conjugate (ADC) (167)
Approvals (4566)
Artificial intelligence (240)
Autoimmune disease (80)
Automation (18)
Bankruptcy (110)
Best Places to Work (3988)
BIOSECURE Act (3)
Biosimilars (100)
Biotechnology (12)
Bladder cancer (118)
Brain cancer (25)
Breast cancer (368)
Cancer (2738)
Cardiovascular disease (224)
Career advice (433)
Career pathing (1)
CAR-T (130)
CDC (7)
Cell therapy (343)
Cervical cancer (22)
Clinical research (23638)
Collaboration (756)
Company closure (1)
Compensation (522)
Complete response letters (20)
COVID-19 (734)
CRISPR (40)
C-suite (300)
Cystic fibrosis (51)
Data (3675)
Depression (53)
Diabetes (234)
Diagnostics (1958)
Digital health (18)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (103)
Drug pricing (49)
Drug shortages (6)
Duchenne muscular dystrophy (99)
Earnings (47805)
Editorial (12)
Employer branding (5)
Employer resources (27)
Events (30928)
Executive appointments (408)
FDA (5917)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (13)
Funding (692)
Gene editing (91)
Generative AI (13)
Gene therapy (266)
GLP-1 (442)
Government (1190)
Grass and pollen (5)
Guidances (343)
Healthcare (5276)
HIV (38)
Huntington's disease (13)
IgA nephropathy (38)
Immunology and inflammation (104)
Immuno-oncology (28)
Indications (55)
Infectious disease (870)
Inflammatory bowel disease (91)
Inflation Reduction Act (3)
Influenza (55)
Intellectual property (76)
Interviews (93)
IPO (6701)
IRA (8)
Job creations (713)
Job search strategy (381)
JPM (11)
Kidney cancer (14)
Labor market (27)
Layoffs (166)
Leadership (4)
Legal (1402)
Liver cancer (36)
Longevity (4)
Lung cancer (393)
Lymphoma (262)
Machine learning (18)
Management (10)
Manufacturing (255)
MASH (82)
Medical device (3793)
Medtech (3812)
Mergers & acquisitions (4154)
Metabolic disorders (618)
Multiple sclerosis (88)
NASH (7)
Neurodegenerative disease (141)
Neuropsychiatric disorders (46)
Neuroscience (1132)
NextGen: Class of 2026 (1413)
Non-profit (1051)
Now hiring (16)
Obesity (295)
Opinion (49)
Ovarian cancer (87)
Pain (85)
Pancreatic cancer (113)
Parkinson's disease (128)
Partnered (6)
Patents (138)
Patient recruitment (205)
Peanut (31)
People (6466)
Pharmaceutical (2)
Pharmacy benefit managers (10)
Phase 1 (6273)
Phase 2 (9936)
Phase 3 (9204)
Pipeline (3361)
Policy (39)
Postmarket research (954)
Preclinical (2076)
Press Release (12)
Prostate cancer (136)
Psychedelics (12)
Radiopharmaceuticals (93)
Rare diseases (383)
Real estate (919)
Recruiting (12)
Regulatory (6613)
Reports (16)
Research institute (464)
Resumes & cover letters (89)
Rett syndrome (23)
RNA editing (3)
RSV (48)
Schizophrenia (72)
Series A (99)
Series B (89)
Service/supplier (1)
Sickle cell disease (55)
Special edition (9)
Spinal muscular atrophy (74)
Sponsored (11)
Startups (597)
Stomach cancer (6)
Supply chain (42)
Tariffs (17)
The Weekly (10)
Vaccines (366)
Venture capital (40)
Weight loss (198)
Women's health (34)
Worklife (6)
Date
Today (50)
Last 7 days (281)
Last 30 days (910)
Last 365 days (15828)
2026 (1487)
2025 (16153)
2024 (13654)
2023 (12586)
2022 (16376)
2021 (16028)
2020 (14213)
2019 (12463)
2018 (9248)
2017 (8431)
2016 (7674)
2015 (8968)
2014 (6474)
2013 (5020)
2012 (5583)
2011 (6090)
2010 (5121)
Location
Africa (198)
Alabama (19)
Alaska (2)
Arizona (64)
Arkansas (4)
Asia (11477)
Australia (1899)
California (5730)
Canada (1410)
China (534)
Colorado (223)
Connecticut (265)
Delaware (232)
Europe (27721)
Florida (649)
Georgia (172)
Hawaii (3)
Idaho (18)
Illinois (442)
India (24)
Indiana (238)
Iowa (8)
Japan (286)
Kansas (30)
Kentucky (18)
Louisiana (15)
Maine (32)
Maryland (537)
Massachusetts (4247)
Michigan (103)
Minnesota (280)
Mississippi (3)
Missouri (61)
Montana (9)
Nebraska (4)
Nevada (70)
New Hampshire (28)
New Jersey (1603)
New Mexico (8)
New York (1392)
North Carolina (583)
North Dakota (5)
Northern California (2826)
Ohio (147)
Oklahoma (5)
Oregon (9)
Pennsylvania (944)
Puerto Rico (5)
Rhode Island (13)
South America (293)
South Carolina (10)
Southern California (2154)
Tennessee (81)
Texas (883)
United States (19357)
Utah (143)
Vermont (1)
Virginia (137)
Washington D.C. (18)
Washington State (434)
West Virginia (2)
Wisconsin (90)
189,686 Results for "7".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NextPoint Therapeutics Announces Clinical Entry of NPX372, a First-in-Class B7-H7–Targeted T Cell Engager to Treat Solid Tumors
February 10, 2026
·
2 min read
Press Releases
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit
February 11, 2026
·
6 min read
Press Releases
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit
January 22, 2026
·
1 min read
Deals
Roche Keeps the Deals Coming With up to $1.7B SangeneBio RNAi Pact
The alliance will add to Roche’s RNAi efforts, which include the hypertension candidate zilbesiran, partnered with Alnylam under a July 2023 agreement.
February 3, 2026
·
1 min read
·
Tristan Manalac
Job Trends
7 Companies Hiring in South San Francisco
Job listings in the area have ticked up in the last month. These seven companies are hiring in South San Francisco right now, including scientist and clinical roles.
December 4, 2025
·
1 min read
·
Chantal Dresner
Mergers & acquisitions
The 7 Most Impactful M&A Deals of 2025
These deals radically reshaped the biopharma world, either by one vaccine rival absorbing another, a Big Pharma doubling down after another failed acquisition or, in the case of Pfizer and Novo, two heavyweights duking it out over a hot obesity biotech.
December 17, 2025
·
7 min read
·
Dan Samorodnitsky
Press Releases
L7 Informatics: Life Sciences Must Move from AI-Ready to AI-Actionable
Execution layers are required to turn AI recommendations into governed action in regulated workflows.
January 26, 2026
·
1 min read
Press Releases
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
February 11, 2026
·
5 min read
Press Releases
ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial
December 3, 2025
·
5 min read
Press Releases
QurAlis Confirms Signal of Target Engagement in ALS Patients in Phase 1 Clinical Trial of QRL-101, a Potentially Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener
December 29, 2025
·
4 min read
1 of 18,969
Next
